Grant Award Details

Evaluation of Gene Therapy Approaches for Autosomal Recessive Hyper IgE Syndrome Due to Mutations in DOCK8
Grant Number: 
DISC2P-11791
Project Objective: 
  • To evaluate HSC gene therapy approaches for mutations in the large gene DOCK8, which are associated with Hyper IgE Syndrome
Investigator: 
Disease Focus: 
Blood Disorders
Immune Disease
Human Stem Cell Use: 
Adult Stem Cell
Award Value: 
$234,000
Status: 
Closed

Progress Reports

Reporting Period: 
Final Full Progress Reporting

Grant Application Details

Application Title: 
  • Evaluation of Gene Therapy Approaches for Autosomal Recessive Hyper IgE Syndrome Due to Mutations in DOCK8
Public Abstract: 
Statement of Benefit to California: